相关实验视频

Updated: Jul 4, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

癌症老年人减少多药性:一个试点集群随机试验协议

Erika Ramsdale¹, Mostafa Mohamed¹, Holly M Holmes²

¹James P. Wilmot Cancer Center, University of Rochester Medical Center, NY, USA.

Journal of geriatric oncology

|February 1, 2024

概括

这项研究调查了药剂师主导的对老年癌症患者的抑郁处方干预措施. 其目标是改善瘤学环境中的治疗结果和可行性.

科学领域:

老年瘤学老年瘤学
药理学药理学是指药理学的学科.
临床试验设计临床试验设计

背景情况:

多药在患有癌症的老年人中很常见,导致不良结果.
抑郁症干预措施在这个脆弱人群中没有得到充分的研究.
优化药物管理对于癌症治疗成功至关重要.

研究的目的:

评估药剂师主导的抑止处方干预措施的有效性和可行性.
将药剂师主导的干预与患者教育小册子进行比较.
收集试点数据用于更大的全国性临床试验.

主要方法:

一个单站点,集群随机临床试验,涉及患有癌症和多药的老年人.
第一阶段:聚焦小组和采访以调整干预措施;与患者进行试点测试.
第二阶段:试点集群随机试验比较药剂师干预与小册子,瘤学家作为集群.

主要成果:

疗效结果包括化疗剂量强度,药物适当性,毒性和功能状态.
实施结果评估了减缓处方的障碍和促进因素.
试验数据将为未来大规模随机试验的设计提供信息.

结论:

抑郁的干预措施有望改善癌症老年人的治疗结果.
这项研究将提供有关瘤实践中干预有效性和实施的关键数据.
结果将指导第三阶段试验的设计,以优化癌症护理.

关键词:

临床试验临床试验是指临床试验的临床试验.删除描述的内容药剂师药剂师药剂师药剂师多种药房多种药房

更多相关视频

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Hazard Ratio

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...